CompletedNot Applicable

Hyperglycemia in Patients with Stroke and Indication of Enteral Nutrition

Spain52 participantsStarted 2017-12-12

Plain-language summary

The purpose of this study is to evaluate the effect of a specific nutritional formula for diabetics on the development of hyperglycemia in patients with recent non-diabetic stroke who require admission and enteral nutritional support by nasogastric tube. As well as the effect on metabolic control, development of comorbidities, hospital stay, readmissions, mortality and tolerance of the formula under study.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admitted for a first episode of ischemic or hemorrhagic stroke. * Requiring total enteral nutrition by tube for at least 7 days Exclusion Criteria: * Contraindication to enteral nutrition * Diabetes Mellitus * Gastrointestinal disease: ulcer, gastritis, diarrhea, gastroparesis, vomiting, abdominal pain * Need for admission to the ICU * Previous neurodegenerative disease * Antibiotherapy for 7 days prior to the inclusion visit * Allergies or intolerances to any of the components of the formula under study * Pregnant patients

What they're measuring

HYPERGLUCEMIA POST-ENTERAL NUTRITION

Timeframe: 2 WEEKS

Trial details

NCT IDNCT03422900

SponsorEndocrinology and Clinical Nutrition Research Center, Spain

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-30

View on ClinicalTrials.gov More Hyperglycaemia (Non Diabetic) trials